TMX - Terminix sale to Rentokil gets U.S. antitrust approval

Terminix Global (NYSE:TMX) and Rentokil announced that the companies received U.S. antitrust approval for Terminix's sale to Rentokil. TMX share rose 6% in premarket trading. Terminix (TMX) and Rentokil announced that the HSR waiting period for the deal had expired, according to a statement. The parties remain on track for close within the second half of the year and a targeting a close towards the end of Q3. The companies amended the end date of the deal to Dec. 31 from Sept. 13. Rentokil agreed to buy Terminix (TMX) for $6.7B in December.

For further details see:

Terminix sale to Rentokil gets U.S. antitrust approval